Difference between revisions of "OncoMouse"

From Cyborg Anthropology
Jump to: navigation, search
 
(11 intermediate revisions by the same user not shown)
Line 1: Line 1:
 
===Definition===
 
===Definition===
OncoMouse is a term used to describe (a type of laboratory mouse that has been genetically modified using modifications designed by Philip Leder and Timothy A Stewart<ref>European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.</ref> of Harvard University to carry a specific gene called an activated oncogene. The activated oncogene significantly increases the mouse’s susceptibility to cancer, and thus makes the mouse suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.<ref>Trademark: USPTO serial number 75797027</ref>) http://en.wikipedia.org/wiki/Oncomouse
+
OncoMouse is both a noun and a trademark. OncoMouse describes a transgenic mouse carrying an activated human cancer gene, used in laboratory experiments.<ref>New Oxford American Dictionary. 2011.</ref> Philip Leder and Timothy A Stewart<ref>European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.</ref> of Harvard University designed the mouse to carry an activated oncogene, a gene that in certain circumstances can transform a cell into a tumor cell. This makes suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.<ref>Trademark: USPTO serial number 75797027</ref>
  
Oncomouse was engineered with a pump attached to its body in order to understand how to manage human life in long term space travel.  
+
OncoMouse was also the first patented animal. Two patents were awarded to Harvard College describing methods for "providing a cell culture from a transgenic non-human animal".<ref>U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.</ref>
  
Klines and Cline They had a quite Positive view on the ideas of the futur of space travel
+
===Related Reading===
Humans, space, drugs. Environment
+
*Modest_Witness@Second_Millennium.FemaleMan©Meets_OncoMouse™: Feminism and Technoscience, New York: Routledge, 1997 (winner of the Ludwig Fleck Prize). ISBN 0-415-91245-8.
To surmount the everyday conditions of reality in order to ameiloriate the symptoms of everyday reality
+
 
+
Simply give a link to the essay if you use the picture
+
 
+
A Cyborg Handbook.  
+
  
 
==References==
 
==References==

Latest revision as of 04:36, 9 April 2012

Definition

OncoMouse is both a noun and a trademark. OncoMouse describes a transgenic mouse carrying an activated human cancer gene, used in laboratory experiments.[1] Philip Leder and Timothy A Stewart[2] of Harvard University designed the mouse to carry an activated oncogene, a gene that in certain circumstances can transform a cell into a tumor cell. This makes suitable for cancer research. The rights to the invention are owned by DuPont. "OncoMouse" is a registered trademark.[3]

OncoMouse was also the first patented animal. Two patents were awarded to Harvard College describing methods for "providing a cell culture from a transgenic non-human animal".[4]

Related Reading

  • Modest_Witness@Second_Millennium.FemaleMan©Meets_OncoMouse™: Feminism and Technoscience, New York: Routledge, 1997 (winner of the Ludwig Fleck Prize). ISBN 0-415-91245-8.

References

  1. New Oxford American Dictionary. 2011.
  2. European Patent Register entry for European patent no. 0169672, under "Inventor(s)". Consulted on February 22, 2008.
  3. Trademark: USPTO serial number 75797027
  4. U.S. Patent 5,087,571; filed Mar 22, 1988, issued Feb 11, 1992, expired Feb 11, 2009) and testing methods using transgenic mice expressing an oncogene, U.S. Patent 5,925,803; filed Sep 19, 1991, issued Jul 20, 1999, expires July 20, 2016.